← back to search

Jixiang Wu

Nantong University · CN
Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer research, Biology, Lung cancer, Cell growth, Carcinogenesis, and Bladder cancer.
h-index
citations
117
works
9
NIH funding
primary concept
email

Recent publications

LINC01133 regulates MARCKS expression via sponging miR-30d-5p to promote the development of lung squamous cell carcinoma
Translational Oncology 2024cited by 4position: middledoi
Over‐expression of USP15/MMP3 predict poor prognosis and promote growth, migration in non-small cell lung cancer cells
Cancer Genetics 2023cited by 15position: middledoi
Pancancer analysis of the correlations of HS6ST2 with prognosis, tumor immunity, and drug resistance
Scientific Reports 2023cited by 4position: middledoi
<i>OPA1</i> supports mitochondrial dynamics and immune evasion to CD8 <sup>+</sup> T cell in lung adenocarcinoma
PeerJ 2022cited by 17position: middledoi
NUF2 Is a Potential Immunological and Prognostic Marker for Non-Small-Cell Lung Cancer
Journal of Immunology Research 2022cited by 8position: middledoi
LncRNA MTX2-6 Suppresses Cell Proliferation by Acting as ceRNA of miR-574-5p to Accumulate SMAD4 in Esophageal Squamous Cell Carcinoma
Frontiers in Cell and Developmental Biology 2021cited by 14position: middledoi
LINC00518 Promotes Cell Proliferation by Regulating the Cell Cycle of Lung Adenocarcinoma Through miR-185-3p Targeting MECP2
Frontiers in Oncology 2021cited by 11position: middledoi
RETRACTED ARTICLE: A Cu(II) complex: treatment activity on intracerebral hemorrhage via inhibiting inflammatory response in vascular endothelial cells
Inorganic and Nano-Metal Chemistry 2020cited by 0position: lastdoi
&lt;p&gt;Long Noncoding RNA LINC00265 Targets EGFR and Promotes Deterioration of Colorectal Cancer: A Comprehensive Study Based on Data Mining and in vitro Validation&lt;/p&gt;
OncoTargets and Therapy 2019cited by 19position: lastdoi
&lt;p&gt;&lt;em&gt;DUXAP8&lt;/em&gt; a Pan-Cancer Prognostic Marker Involved in the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation&lt;/p&gt;
OncoTargets and Therapy 2019cited by 19position: lastdoi
&lt;p&gt;Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma&lt;/p&gt;
OncoTargets and Therapy 2019cited by 14position: lastdoi
&lt;p&gt;The Long Non-Coding RNA SBF2-AS1 Exerts Oncogenic Functions In Gastric Cancer By Targeting The miR-302b-3p/E2F Transcription Factor 3 Axis&lt;/p&gt;
OncoTargets and Therapy 2019cited by 13position: middledoi
BLACAT1 predicts poor prognosis and serves as oncogenic lncRNA in small‐cell lung cancer
Journal of Cellular Biochemistry 2018cited by 44position: middledoi
XB130 Knockdown Inhibits the Proliferation, Invasiveness, and Metastasis of Hepatocellular Carcinoma Cells and Sensitizes them to TRAIL-Induced Apoptosis
Chinese Medical Journal 2018cited by 14position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jianxiang Song · Nantong University6 papers (2021–2024)Chaojie Liang · South China Agricultural University5 papers (2018–2019) · 4 papers (2019–2019)Hui‐Wen Chang · Utrecht University3 papers (2021–2024)Yajun Zhang · University of Virginia3 papers (2021–2024)Guangming Li · Jinan University3 papers (2018–2019)Hua Ge · Guangdong University of Technology3 papers (2019–2019)Yingchen Xu · Loyola University Chicago3 papers (2018–2019)Zhan Shi · Jiangsu University3 papers (2021–2024)Zhigang Wei · Shanxi Medical University3 papers (2019–2019)Daguang Ni · Nantong University2 papers (2023–2023)Ming Liu · Yangtze University2 papers (2021–2024)Dongxin Zhang · Harbin Medical University2 papers (2018–2019)Youqin Jiang · Nantong University2 papers (2023–2023)Lijun Yan · Shanghai University2 papers (2019–2019)Woda Shi · Fudan University2 papers (2023–2024)Pengyang Li · Virginia Commonwealth University2 papers (2019–2019)Wenyu Shi · Nantong University2 papers (2023–2023)Mengjie Zhao · Nantong University1 papers (2024–2024)He Huang · Anhui Medical University1 papers (2019–2019)